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Objectives .
The purpose of this study was to identify the causes
of oserseasing during ventricular paring in patients with a third-
reiteration implantable cardioverter-defibrillator .
Background. Third-generation implantable cardtoverter-
dehbrllltors have the capability for bradyeardia pacing as well as
andtachycardin pacing and defibrillation . With the Ventrilex
Csdee ceTiered Therapy Defibrillator System, the pulse generator
sensitivity Is increased during bradycardia pacing to prevent
undeesensing of an arrhythmia with small amplitude signals .
Methods.
Records from $5 consecutive patients who underwent
impleataliod of a Cadence device for treatment of ventricular
tachyarrhythmias were reviewed .
Results . Four patients required continuous pacing for bradyar-
rhythmlas . In three of these patients, ventricular pacing was
accomplished oft the bradyeardia pacing feature of the Cadence
devise. All three experienced spurious device discharges or had
aborted shocks for oeeraensiog . Analysis of real-time and stored
Several third-generation implantable cardioverter-defibrillator
systems have the capability for bradycandia pacing as well as
antitachycardia pacing and cardioversion-defibrillation (I) .
This, in theory, allows the use of a single device in patients
who have both bradyarrhythmias and tachyarrhythmias .
Such a system should not only be more simple and less
costly than using two separate devices but should avoid
problems of adverse pacemaker-defibrillator interactions
(2-5).
The Ventritex Cadence Tiered Therapy Defibrillator Sys-
tem (Venlritex, Inc.) is a multiprogrammable antitachycar-
dia device with the capability for backup bradycardia pacing .
Its options for tachyarrhythmia therapy include antitachy-
cardia pacing as well as cardioversion and defibrillation.
Cardioversion and defibrillation therapy are "no---commit-
ted." In other words, the device is capable of continuously
monitoring the rhythm during the charging of its capacitors .
Therapy will not be delivered if the average heart rate slows
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electrograms revealed intermittent high frequency, large ampli-
tude noise in two patients and oversensing of masimafy gained R
and T waves in the remaheing patient
. No evidence of lead fracture
was found in any patient, The problem was solved by implantation
of a separate permanent pacemaker to two patients and was
partially solved by reprogramming of the device in the remaining
patient.
Conclusions. Although the Cadence implantable cardtovereer-
defibriBator
,
has the capability for ventricular pacing in patients
with beadyarrhythmtas, certain features of its automatic gain
control circuit limit its utility in this instance . Oversemsing occurs
commonly, leading to device discharges or aborted shocks . Im-
plantation of a separate permanent pacemaker may be required in
patients who have a Cadence device for taehyarrhythmta control
and who also need pacing for bredycardie.
(J Am Cell Cordial 1994
;23x1531-4)
below the programmed rate cutoff before shock delivery .
Moreover, the device is capable of displaying real-time
eleetrograms, recorded from the pacing-rate-sensing lead, as
well as storing the intracardiac electrograms during episodes
of antitachycardia pacing, cardioversion, defibrillation and
aborted shocks .
To evaluate the occurrence and nature
of
pacemaker-
defibrillator interactions with the Cadence device, data from
85 patients who underwent defibrillator implantation at this
institution were reviewed .
Methods
Eighty-five patients with a history of
sustained ventricu-
lar arrhythmias underwent implantation of a Cadence Tiered
Therapy Defibrillator System at this institution between
February 1991 and August 1993
. After hospital discharge,
patients were seen at a minimum of once every 2 months
. At
each visit, the patients were questioned regarding the occur-
rence of any device discharges or symptoms, such as palpi-
tations, syncope or near-syncope . The devices were interro-
gated, and pacing thresholds, R waves and lead impedances
were measured . Real-time electrograms were recorded, and,
if
there had been any tachyarrhythmia therapy delivered
0735.109719457 .00
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Ftgare 1 . Stored eketrogram from Patient 1 . Continuous recording
at 25 mm/s of stored electrogram from an aborted shock. The
beginning of the top Gating shows ventricular pacing at cycle length
800 ms . After the third beat there is high frequency electrical activity
mad arrow that increases in amplitude and inhibits pacing apes
arrow . There is a slow escape rhythm at cycle length 1 .010 ms. The
noise was erroneously sensed as a tachyanrhythmia and led to
device
charging with an aborted shock .
since the previous visit, all available
stored electrograms
were retrieved and analyzed .
Results
Four of the 05 patients in our series required continuous
pacing for bradyarrhythmias . In three of these patients,
pacing was accomplished by means of the Cadence device.
All three patients experienced spurious device discharges or
had aborted shocks because of oversensing .
Patient 1
. A 74-year old man suffered an out-of-hospital
cardiac arrest in August 1992 . He underwent implantation of
a Cadence V-100 device using two epicardial defibrillating
patches Cardiac Pacemakers, Inc., model L67 and two
epicardial screw-in leads for sensing and pacing Cardiac
Pacemakers, Inc ., model MLISO . At the time of Cadence
implantation, a unipolar pacemaker, implanted in 1988 for
complete heart block, was explained . The Cadence was
programmed for bradycardia pacing at 75 beats/min, The
bradycardia pacing refractory period was extended from
the
nominal value of 350 to 500 ms to prevent T-wave oversens-
ing . In January 1993, interrogation of the device revealed
three aborted and one delivered shock . Analysis of stored
electrograms from the three available events showed inter-
mittent high frequency, large amplitude electrical signals
that were independent of the underlying rhythm, consistent
with electrical noise Fig . 1 . Chest X-ray film revealed no
evidence of lead dislodgment or fracture ; the pacing thresh-
old and lead impedance were unchanged from previous
values.
The device was reprogrammed from the Defibrillator
with No Tachycardia Response mode rate cutoff 167
beats/min
to the Defibrillator with Tachycardia Response/
Single Tachycardia Discrimination mode so that the num-
ber of intervals required for response could be prolonged
IACC Voi. 23 . No
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Figure 2 . Real-time electrogram recording from portent 1 . The
beginning of the tracing shows ventricular pacing at cycle length
800 ms
. The patient is supine and shifting slowly Goes
side to side .
With movement . there is high frequecy noise that reaches sufficient
amplitude to be sensed by the device and inhibit pacing meow .
programmed to 20 . The rate cutoff for tachycardia was set
at 167 beats/min . The rate cutoff for fibrillation was set at 222
beats/min. No further events were documented until July
1993, when interrogation of the device showed another
aborted shock for electrical noise. In addition, analysis of
real-time electrograms showed noise with oversensiag and
pacemaker inhibition during movement and position change
Fig. 2 . A sensing lead fracture was suspected, and the
patient was taken to the operating room for placement of a
new lead. In the operating room, real-time electrogram
recordings from the pacing lead showed frequent electrical
noise that was worsened by manipulation of the leads and
adaptor Daig Corporation, model LA 211 . Visual inspec-
tion revealed no obvious disruption of the adaptor or the
proximal portions of the leads . The adaptor was changed
without improvement. The pacing threshold of the epicardial
leads was 1 .3 V at I-ms pulse width, and the lead impedance
was 760 ohms. A bipolar endocardial lead Medtronic . Inc.,
model 502AM was placed in the right ventricular apex
through the right subclavian vein . Despite stable positioning,
the noise on the real-time ekctrograms persisted. For that
reason, a bipolar dual-chamber pacemaker was implanted.
Real-tbx eleetrograins from the new endocardial
sensing
led were then obtained during pacing by the Cadence
device and then -10 s later during pacing by the permanent
pacemaker. As can be seen in Figure
3, pacing by the
permanent pacemaker eliminated the extraneous noise that
was seen during Cadence pacing, suggesting this the prob-
lem was not a result of a defect in the sensing lend itself.
Pat net 2. A 68-year old man had an episode of sustained
ventricular
tachycardia
in October 1992. A Cadence V-100
device was implanted using two epicardial patches Cardiac
Pacemakers, Inc., model 1 .67 for defibrillation and a bipolar
endacardial lead Medtronic, Inc., model 4004M for pacing
and sensing. At the time of implantation, a unipalar ventric-
ular pacemaker, implanted in March 1992 for heart block,
was explanted. The Cadence was programmed for bmdycar-
dia pacing at 80 beats/min, and the bradycardia pacing
refractory period was programmed to 500 ms. Interrogation
of the device in December 1992 showed that there had been
one aborted shock. Analysis of the stored electrogram from
that event Fig. 4 . showed some spontaneous nonpaced
beats with over-sensing; of maximally gained R and T waves.
Chest X-ray film, pacing threshold and lead impedance were
3ACC Vat. 23, Na. 7
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Figern 3. Intraopemtive real-time electrogram from Patient 1 . Top
tearing is a real-time electrogram at 25 mm/s recorded during
pacing with the Cadence device . Electrical artifact is present imer-
mittently throughout the tracing arrows , The lower tracing ob-
tained within seconds of the top recording was recorded during
pacing with the permanent pacemaker
. The tracing is
free of
extraneous noise .
all unchanged from previous values. The device was repro-
grammed from the Defibrillator with No Tachycardia Re-
sponse mode to the Defibrillator with Tachycardia Re-
sponselSingle Tachycardia Discrimination mode. The rate
cutoffs were set at 140 beats/min for tachycardia with 20
intervals required for response and 207 beatslmin for fioril-
lation. One month later, device interrogation showed 14
additional aborted shocks. Analysis of the three available
stored electrograms again showed oversensing of maximally
gained spontaneous beats. No change was made in the
programmed variables until May 1993, when another nine
aborted shocks were documented . At that time, the fibrilla-
tion detection time was reprogrammed from nominal to
slow. During the next 3 months, a single aborted shock
was documented .
Patient 3
. A 66-year old man with
a
history of cardiac
arrest underwent implantation of a Ventritex Cadence de-
vice model V-100 in October 1991
. The system consisted of
one epicardial patch
Cardiac Pacemakers, Inc ., model L67 ,
a transvenous coil
Cardiac Pacemakers, Inc ., model CIO
positioned at the high right atrialisuperior vena caval junc-
tion and a bipolar endocardial lead
Cardiac Pacemakers,
F9gane 4. Stored eteetrograer from Patient 2 . The beginning of the
tracing shows ventricular pacing at 750 ms
. After two paced beats
there are spontaneous beats
meow in which the R and T waves are
amplified to sufficient amplitude to be counted multiple times and
initiate charging of the device and an aborted shock .
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Fgure 5. Stored electrogram horn Patient 3. Continuous recording
at 25 mmls of stored etectrogeam from an aborted shock. Top
tracing shows electrical noise that is of sufficient amplitude, fre-
quency and duration to trigger device charging and an aborted
shock . By the middle of the tower tracing the noise has resolved, and
there is ventricular pacing at cycle length 1,000 ms .
Inc ., model BTIO placed in the right ventricular apex . In
February 1993, amiodarone therapy was begun for an in-
creased frequency of device discharges. Sinus bradycmilia
with fatigue and exercise intolerance developed, and in May
1993, the bradycardia pacing rate of the Cadence device was
reprogrammed from 40 to 60 beatstmin . This resulted in the
patient's rhythm being 100% paced . Interrogation of the device
I week later showed three aborted shocks since the repro-
gramming . Analysis of the stored electrognnnls revealed
intermittent high frequency signals consistent with electrical
noise Fig . 5 . Chest X-ray film, pacing threshold and lead
impedance were unchanged from previous values .
The rate cutoff for ventricular fibrillation was increased
from 171 to 200 beats/min, and the fibrillation detection time
was programmed to
slow. The patient experienced a
device discharge the following day. Analysis of stored elec-
trograms again showed oversensing of electrical noise
. The
bmdycardia pacing rate was reprogrammed to 40 beats/min
resulting in only occasional paced rhythm . No further
sensing problems were documented ; however, because of
persistent fatigue, a bipolar dual-chamber pacemaker was
implanted
. There have been no adverse interactions between
the two devices .
Discussion
This report describes three patients with Cadence im-
plantable defibrillators who experienced spurious device
discharges or aborted shocks that occurred during ventricu-
lar pacing with the Cadence device. The problem was solved
by implantation of a permanent pacemaker in two patients
and partially solved by reprogramming of the device in the
remaining patient .
The exact incidence of this problem is difficult to deter-
mine
. Although only 3 Gf our g5 patients were known to have
a paced rhythm 100% of the time and a 3 experienced
oversensing , it is not known what percent of the remaining
patients experienced intermittent bradyeardia pacing or how
frequently they were paced .
The etiology of the problem is most likely a result of a
feature of the Cadence device itself. The Cadence V-100 and
V-1000 models use an automatic gain circuit to sense
incoming signals . During pacing for bradyeardia, the sensi-
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tivity is maximally increased to prevent undersensing of an
arrhythmia with small amplitude signals. To prevent T wave
oversensing, the bradycardia pacing refractory period can be
programmed to a maximum of 500 ms. In Patients I and 3,
the sensed events causing false tachyarrhythmia detection
seemed to be random electrical noise at maximal gain , not
simply T waves. In Patient 2, occasional spontaneous beats
that occurred during ventricular pacing, and therefore at
maximal gain, were most likely double and triple counted .
Because the refractory period decreases to nominal
-120 ms with the cessation of pacing, extending the
bradycardia pacing refractory period did not ameliorate this
problem.
In two patients the fibrillation detection time was repro-
grammed from nominal to slow. This feature, designed
to prevent repeated device chargings for nonsustained tachy-
arrhythmias, may have been of some benefit in the second
patient described earlier, who has had only one oversensed
event since this was done .
In two patients, the mode of the device was repro-
grammed from Defibrillator with No Tachycardia Re-
sponse to Defibrillator with Tachycardia Response so
that tine number of intervals required for sensing could be
prolonged. This did not seem to be of benefit, perhaps
because the high frequency of the noise committed it to
detection in the fibrillation category .
Disruption of the rate-sensing lead-adaptor system with
resultant electrical artifact and spurious device discharge has
been previously reported with this system 6 . Because
abnormalities caused by lead fracture or disruption can be
intermittent, the normal pacing thresholds and impedances
in our patients do not completely rule this out . However, we
consider that this alone is an unlikely explanation for several
reasons, All three patients with this problem were ventricu-
larly paced each time it occurred . In Patient 2, the over-
sensed events seemed clearly correlated to maximally gained
spontaneous beats, not to background electrical noise
. In the
other two patients, although minute disruptions in the sens-
ing leads might well be the origin of the electrical noise, the
problem seemed to result from sensing at maximal gain.
Patient 3 had gone for a long period of time after implant
JACC V.I. 23 . No. 7
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without pacing for bradycardia and without sensing prob-
lems. The oversensing was temporally correlated to an
increase in his programmed pacing rate, resulting in constant
ventricular pacing. In addition, in Patient 1, changing the
adaptor and implantation of a new endocardial lead did not
eliminate the electrical noise recorded from the lead . In
Patients I and 3, implantation of a separate permanent
pacemaker put an end to the frequent aborted shocks .
Finally, inuaoperative recordings from the lead during pac-
ing by the permanent pacemaker in Patient I were entirely
normal, whereas recording during pacing by the Cadence
showed frequent electrical noise Fig. 3 .
Conclusions . Although the Cadence implantable
cardioverterdefibrillator has the capability for ventricular
pacing in patients with bradyarrhythmias. certain features of
its automatic gain control circuit limit its utility in this
instance . 3versensing during pacing occurs commonly, lead-
ing to device discharges or aborted shocks . Reprogramming
of the device may be of some benefit; however, implantation
of a separate permanent pacemaker or use of an alternative
third-generation device may be required in patients who
require device therapy for both bradyarrhythmias and tachy-
arrhythmias .
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